Literature DB >> 15812403

Efficacy of an overtube for reducing the risk of peristomal infection after PEG placement: a prospective, randomized comparison study.

Iruru Maetani1, Masatoshi Yasuda, Masahiro Seike, Masaki Ikeda, Tomoko Tada, Takeo Ukita, Yoshihiro Sakai.   

Abstract

BACKGROUND: With the conventional pull method of PEG placement, there is a significant risk of wound infection from contamination of the gastrostomy catheter as it passes through the oral cavity. This study compared the occurrence of peristomal wound infection associated with PEG placement with and without use of an overtube.
METHODS: Consecutive patients with dysphagia were randomized to undergo PEG placement with (Group I) or without (Group II) an overtube. For each patient, the peristomal area was evaluated daily for 1 week after PEG placement. The presence of erythema and of exudate were scored on a scale of 0 to 4; induration was scored on a scale of 0 to 3. Criteria for infection were a maximum combined score of 8 or higher, or the presence of microscopic and microbiologic evidence of suppurating exudate. In each group, cefazolin was administered prophylactically (2 g/d intravenously) for 3 days. For patients who had received an antibiotic(s) before PEG placement, the same antibiotic(s) was used. All procedures in both groups were performed by one of two investigators who used the pull method.
RESULTS: A total of 76 patients were randomized; 3 were excluded from analysis, because death occurred within 1 week after the procedure. Two of 3 deaths were procedure-related (aspiration pneumonia in Group I, peritonitis in Group II). Data for 37 patients in Group I and 36 in Group II were analyzed. There was no significant difference between the groups with respect to baseline characteristics. The occurrence of peristomal infection within 1 week of PEG was significantly lower in Group I compared with Group II (2 vs. 12; p = 0.0029). The mean daily combined scores in Group I also were significantly lower than those in Group II ( p < 0.0001), and the median maximum parameter scores in Group I were significantly lower than those in Group II (erythema, p = 0.0062; induration, p = 0.0390; exudate, p < 0.0001), although the nominal significance for induration was removed by correction for the multiple testing of data. One patient excluded from Group II died from sepsis because of procedure-induced peritonitis. Among the 73 enrolled patients, there was no procedure-related mortality or clinically important wound infections that required surgical intervention in either group.
CONCLUSIONS: Use of an overtube during PEG placement reduces the risk of peristomal wound infection.

Entities:  

Mesh:

Year:  2005        PMID: 15812403     DOI: 10.1016/s0016-5107(05)00012-x

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  4 in total

1.  The introducer technique is the optimal method for placing percutaneous endoscopic gastrostomy tubes in head and neck cancer patients.

Authors:  Jason M Foster; Peter Filocamo; Hector Nava; Michael Schiff; Wesley Hicks; Nestor Rigual; Judy Smith; Thom Loree; John F Gibbs
Journal:  Surg Endosc       Date:  2006-12-16       Impact factor: 4.584

Review 2.  Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy.

Authors:  Allyson Lipp; Gail Lusardi
Journal:  Cochrane Database Syst Rev       Date:  2013-11-14

3.  Feasibility and Safety of Overtubes for PEG-Tube Placement in Patients with Head and Neck Cancer.

Authors:  Crispin O Musumba; Julia Hsu; Golo Ahlenstiel; Nicholas J Tutticci; Kavinderjit S Nanda; David van der Poorten; Eric Y Lee; Vu Kwan
Journal:  Gastroenterol Res Pract       Date:  2015-04-21       Impact factor: 2.260

4.  Usage characteristics and adverse event rates ​of the direct puncture and pull techniques for percutaneous endoscopic gastrostomy in patients with malignant tumors of the upper aerodigestive tract.

Authors:  Niels Teich; Lars Selig; Susanne Liese; Franziska Schiefke; Alexander Hemprich; Joachim Mössner; Ingolf Schiefke
Journal:  Endosc Int Open       Date:  2018-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.